Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > NY Providers > Oncologists

Dr. Ingo K. Mellinghoff, MD, FACP

Accepting New Patients

(Ingo K. Mellinghoff, MD, FACP - MSK Neuro-Oncologist)

(27 Ratings)

Specializes in: Oncology (Cancer Care), Psychiatry & Neurology, General Practice, Neuro-Oncology and Internal Medicine (Adult Medicine)

160 East 53rd Street New York
Rockefeller Outpatient Pavilion, NY 10022

(646) 888-3036

Dr. Ingo K. Mellinghoff, MD, FACP is an oncologist in New York, NY specializing in oncology (cancer care), psychiatry & neurology, general practice, neuro-oncology and internal medicine (adult medicine). Dr. Ingo K. Mellinghoff, MD, FACP is affiliated with Memorial Sloan Kettering Cancer Center and MEMORIAL NEUROLOGY GROUP.

Office Locations

160 East 53rd Street Between 67th and 68th Streets
New York, NY 10022

open_in_new

Memorial Sloan Kettering Cancer Center

160 East 53rd Street New York
Rockefeller Outpatient Pavilion, NY 10022

(646) 888-3036

open_in_new

In The News (see more mentions in the news)

“Bolton's neuro-oncologist Dr. Ingo Mellinghoff told People that they managed to remove Bolton's glioblastoma, an aggressive brain tumor, in its entirety - and that the success rate for this type of...”—"Michael Bolton Breaks Silence On Brain Cancer Diagnosis: 'I Want To Keep Going'", Huff Post, April 2025

“Similarly, median time to next intervention (TTNI) was not estimable with vorasidenib versus 20.1 months for the placebo group, reported Ingo K. Mellinghoff, MD, of Memorial Sloan Kettering Cancer...”—"IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-Up", MedPage Today, November 2024

“Vorasidenib "has the potential to change the landscape in this disease," said investigator Ingo Mellinghoff, MD, of Memorial Sloan Kettering Cancer Center in New York City, when the INDIGO findings...”—"FDA Approves Vorasidenib for IDH-Mutant Gliomas", MedPage Today, August 2024

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

Volume of procedures performed by Dr. Ingo K. Mellinghoff, MD, FACP for Medicare patients.

doctor visit	60

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

Volume of procedures performed by Dr. Ingo K. Mellinghoff, MD, FACP for Medicare patients.

doctor visit	43

Medicare Procedure and Patient Information

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP.

**Ethnicity**
Non-Hispanic White	24
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

Volume of procedures performed by Dr. Ingo K. Mellinghoff, MD, FACP for Medicare patients.

doctor visit	33

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

Volume of procedures performed by Dr. Ingo K. Mellinghoff, MD, FACP for Medicare patients.

doctor visit	59

Conditions of Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP in 2018

The most common conditions of Medicare patients that Dr. Ingo K. Mellinghoff, MD, FACP treated during 2018 were hypertension.

Hypertension	58
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

Volume of procedures performed by Dr. Ingo K. Mellinghoff, MD, FACP for Medicare patients.

doctor visit	54

Conditions of Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP in 2019

The most common conditions of Medicare patients that Dr. Ingo K. Mellinghoff, MD, FACP treated during 2019 were hypertension.

Hypertension	62
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

Volume of procedures performed by Dr. Ingo K. Mellinghoff, MD, FACP for Medicare patients.

doctor visit	55

Conditions of Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP in 2020

The most common conditions of Medicare patients that Dr. Ingo K. Mellinghoff, MD, FACP treated during 2020 were hypertension.

Hypertension	55
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

Volume of procedures performed by Dr. Ingo K. Mellinghoff, MD, FACP for Medicare patients.

doctor visit	90

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP.

**Gender**
Male	14
Female	15

**Age**
From 65 to 74	15
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP in 2021

The most common conditions of Medicare patients that Dr. Ingo K. Mellinghoff, MD, FACP treated during 2021 were hypertension, high cholesterol and depression.

Hypertension	55
High Cholesterol	45
Stroke	0
Ischemic Heart Disease	0
Depression	38
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

Volume of procedures performed by Dr. Ingo K. Mellinghoff, MD, FACP for Medicare patients.

doctor visit	110

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP.

**Gender**
Male	14
Female	16

**Age**
From 65 to 74	15
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP in 2022

The most common conditions of Medicare patients that Dr. Ingo K. Mellinghoff, MD, FACP treated during 2022 were high cholesterol, hypertension, depression and stroke.

Hypertension	70
High Cholesterol	70
Stroke	37
Ischemic Heart Disease	0
Depression	40
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

Volume of procedures performed by Dr. Ingo K. Mellinghoff, MD, FACP for Medicare patients.

doctor visit	127

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP.

**Gender**
Male	19
Female	18

**Age**
From 65 to 74	22
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP in 2023

The most common conditions of Medicare patients that Dr. Ingo K. Mellinghoff, MD, FACP treated during 2023 were high cholesterol, hypertension, stroke and depression.

Hypertension	70
High Cholesterol	75
Stroke	43
Ischemic Heart Disease	0
Depression	30
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2013 - 2023

Volume of procedures performed by Dr. Ingo K. Mellinghoff, MD, FACP for Medicare patients.

doctor visit	70

Average Medicare Patient Data From 2013 - 2023

Information about Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP.

**Gender**
Male	4
Female	4

**Ethnicity**
Black / African American	0
Asian / Pacific Islander	0
Non-Hispanic White	2
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
75 to 84	0
85 and over	0
Less than 65	0
65 to 74	5

Average of Total of Conditions of Medicare patients treated by Dr. Ingo K. Mellinghoff, MD, FACP From 2013 - 2023

The highest averages of the most common conditions of Medicare patients that Dr. Ingo K. Mellinghoff, MD, FACP treated were hypertension, high cholesterol, depression and stroke.

Hypertension	37
High Cholesterol	19
Stroke	8
Ischemic Heart Disease	0
Depression	10
Chronic Kidney Disease	0
Asthma	0
Osteoporosis	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Atrial Fibrillation	0
Cancer	0
Dementia	0

Education & Training

He completed residency at University of California Los Angeles. He is certified by the Board Certification: Hematology and has a state license in California.

Residency: University of California Los Angeles (1999)

Board Certification: Board Certification: Hematology

Licensed In: California

Affiliations & Hospitals

Dr. Ingo K. Mellinghoff, MD, FACP is associated with these hospitals and organizations:

Memorial Sloan Kettering Cancer Center

MEMORIAL NEUROLOGY GROUP

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Ingo K. Mellinghoff, MD, FACP appears to accept the following insurance providers: Horizon Medicare Advantage, Magnacare, Emblem Essential, Oscar, Fidelis, Healthfirst Medicare Advantage, Healthsmart, Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan), Aetna, Tricare, Oxford, Husky CT Medicaid, Healthfirst, Cigna, Qualcare, MVP, Connecticare, First Health, Multiplan/Beech Street/PHCS, World Trade Center Health Program (WTC), Blue Cross Blue Shield states outside of NY/NJ, Empire Essential, Non-Participating Plans with Out of Network Benefits, Blue Cross Blue Shield New York, Blue Cross Blue Shield Federal Employee Program, UMR, Carrum Health, Medicare Part A&B (traditional Medicare) and Blue Cross Health Plus.

Insurance Accepted by Provider includes:

According to our sources, Dr. Ingo K. Mellinghoff, MD, FACP accepts the following insurance providers:

Horizon Medicare Advantage

Magnacare

Emblem Essential

Oscar

Fidelis

Healthfirst Medicare Advantage

Healthsmart

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

Aetna

Tricare

Oxford

Husky CT Medicaid

Healthfirst

Cigna

Qualcare

MVP

Connecticare

First Health

Multiplan/Beech Street/PHCS

World Trade Center Health Program (WTC)

Blue Cross Blue Shield states outside of NY/NJ

Empire Essential

Non-Participating Plans with Out of Network Benefits

Blue Cross Blue Shield New York

Blue Cross Blue Shield Federal Employee Program

UMR

Carrum Health

Medicare Part A&B (traditional Medicare)

Blue Cross Health Plus

Ratings & Reviews

Dr. Ingo K. Mellinghoff, MD, FACP has an exceptional overall rating with an average of 4.93 out of 5 stars based on 27 ratings. We collect ratings and reviews of Dr. Ingo K. Mellinghoff, MD, FACP from all over the web to help you find the right in New York, NY.

4.93

Overall Rating

(27 Ratings)

Leave a Review

Reviews Left On DocSpot

Overall Rating: 5.0 2023-03-02

Dr Mellinghoff is a highly experienced, seasoned professional who treats people like individuals rather than a statistic or norm.  He has significant depth of knowledge, but is also relevant with current treatments and options in a rapidly changing field.  He works well in collaboration with other providers and institutions to get to the best solution.  Dr Mellinghoff’s office staff is also available, approachable and knowledgeable.

General Payments

These charts describe general payments received by Dr. Ingo K. Mellinghoff, MD, FACP. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Servier Pharmaceuticals LLC	$19,941 TIBSOVO $5,280	$14,661
Agios Pharmaceuticals, Inc.	$8,984 TIBSOVO $7,199	$1,785
F. Hoffmann-La Roche AG	$6,005 Non-Covered Product $6,005
Servier BioInnovation	$5,071 $5,071
Servier Affaires Medicales	$4,401 $4,401
Other	$7,267 Nerlynx $3,015	NonCovered Product $59	$4,192

**Types of Payments**
Consulting Fee	$47,647
Travel and Lodging	$2,805
Food and Beverage	$1,217

Research Payments

Dr. Ingo K. Mellinghoff, MD, FACP has received 678 research payments totaling $15,893,901.

Biography

Dr. Ingo Mellinghoff is a physician who specializes in general practice and neuro-oncology. His residency was performed at a hospital affiliated with the University of California, Los Angeles (UCLA). He is rated highly by his patients. Dr. Mellinghoff's distinctions include: Castle Connolly: America s Top Doctor; Castle Connolly: Top Doctors; and Top Doctors New York Metro Area, Castle Connolly. Dr. Mellinghoff is professionally affiliated with Memorial Sloan Kettering Cancer Center. Yext reports that he is accepting new patients at his office in New York, NY.